期刊文献+

基质交感分子1和骨保护素对急性冠脉综合征合并2型糖尿病患者经皮冠状动脉介入治疗术后支架内再狭窄的影响研究 被引量:10

Influence of STIM1 and OPG on In- stent Restenosis in Patients With ACS Complicated With T2DM After PCI
下载PDF
导出
摘要 目的探讨基质交感分子1(STIM1)和骨保护素(OPG)对急性冠脉综合征(ACS)合并2型糖尿病(T2DM)患者经皮冠状动脉介入治疗(PCI)术后支架内再狭窄(ISR)的影响。方法选取2012年10月—2013年10月河北医科大学第三医院心内科收治的100例ACS合并T2DM患者为研究对象,均成功行PCI术。于术后8个月复查冠状动脉造影,根据是否存在ISR,分为ISR组35例和对照组65例。记录100例患者的性别、年龄、高血压、吸烟等一般资料;在PCI术前,测定患者的高敏C反应蛋白(hs-CRP)、血脂、血糖等生化指标;在PCI术后,测定患者的STIM1和OPG水平。结果两组的年龄、性别、吸烟率、高血压患病率比较,差异均无统计学意义(P>0.05)。两组患者的总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、空腹血糖(FPG)水平比较,差异均无统计学意义(P>0.05);hs-CRP、STIM1、OPG水平比较,差异均有统计学意义(P<0.05)。多因素Logistic回归分析显示,hs-CRP、STIM1、OPG对PCI术后发生ISR的影响有统计学意义(P<0.05)。结论 STIM1、OPG是ACS合并T2DM患者PCI术后发生ISR的危险因素。 Objective To investigate the influence of stromal interaction molecule 1 ( STIM1 ) and osteoprotegerin ( OPG) on in-stent restenosis ( ISR) in patients with acute coronary syndrome ( ACS) complicated with type 2 diabetes mellitus (T2DM) after percutaneous coronary intervention ( PCI) .Methods We enrolled 100 patients with ACS complicated with T2DM who were admitted into the Department of Cardiology of the Third Hospital of Hebei Medical University from October 2012 to October 2013.PCI was undertaken successfully on all the subjects .Eight months after surgery , coronary arteriography was conducted again.According to whether ISR occurred , we divided the subjects into two groups: ISR group ( n=35) and control group (n=65) .General data of the 100 subjects were recorded, including gender, age, hypertension and smoking; before PCI, we tested hs-CRP, blood lipid and blood glucose; after PCI, we determined STIM1 and OPG levels.Results The two groups were not significantly different (P〉0.05) in age, gender, smoking rate, prevalence of hypertension.The two groups were not significantly different ( P 〉0.05 ) in TC, TG, HDL-C, LDL-C and FPG; the two groups were significantly different (P〈0.05) in the levels of hs-CRP, STIM1 and OPG.Multivariate logistic regression analysis showed that hs-CRP, STIM1 and OPG had significant influence on ISR in subjects after PCI ( P〈0.05 ) .Gonclusion STIM1 and OPG are risk factors for patients with ACS complicated with T 2DM after PCI.
出处 《中国全科医学》 CAS CSCD 北大核心 2015年第22期2680-2683,共4页 Chinese General Practice
基金 河北省卫生厅科研基金项目(20120105)
关键词 支架内再狭窄 血管成形术 气囊 冠状动脉 基质交感分子1 骨保护素 影响因素分析 In- stent restenosis Angioplasty, balloon, coronary artery Stromal interaction molecule 1 Osteoprotegerin Root cause analysis
  • 相关文献

参考文献16

二级参考文献22

  • 1向光大,孙慧伶,赵林双,侯洁,乐岭,徐琳.1型糖尿病患者胰岛素治疗前后血浆护骨素的变化[J].中华医学杂志,2007,87(18):1234-1237. 被引量:31
  • 2SIGWART U, PUEL J, MIRKOVITCH V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty[J]. N Engl J Med, 1987, 316(12): 701-706.
  • 3COLOMBO A, HALL P, NAKAMURA, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance[J]. Circulation, 1995, 91(6): 1676-1688.
  • 4SULLIVAN MD, LACROIX AZ, SPERTUS JA, et al. Depression predicts revascularization procedures for 5 years after coronary angiography[J]. Psychosom Med, 2003, 65(2): 229-236.
  • 5TOGNI M, WINDECKER S, COCCHIA RR, et al. Sirolimus-eluting stents associated with paradoxic Coronary vasoconstriction[J]. J Am Coil Cardiol, 2005, 46(2): 231-236.
  • 6TOGNI M, RABER L, COCCHIA R, et al. Local vascular dysfunction after coronary paclita.xel-eluting stent implantation[J]. Int J Cardiol, 2007, 120(2): 219-220.
  • 7NISHIO K, SAKURAI M, KUSUYAMA T, et al. A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes[J]. Diabetes Care, 2006, 29(1): 101-106.
  • 8Wannamethee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men withcoronary heart disease[J].Heart,2004,90:1398 - 403.
  • 9Kastrati A,Schomig A,Elezi S,et al. Predictive factors of resteno- sis after coronary stent placement[J]~. J Am Coll Cardiol, 1997,30: 1428 - 1436.
  • 10Komowski R,Mintz GS,Kent KM,et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia:A serial intravascular ultrasound study [J]. Circula- tion, 1997,95:1366 - 1369.

共引文献119

同被引文献88

  • 1Ota H,Takehara N,Aonuma T, et al. Association between mi- croalbuminuria predicting in-stent restenosis after myocardial in- farction and cellular senescence of endothelial progenitor ceils [J]. PLoS One, 2015,10(4) :e0123733.
  • 2Xu BY, Xiang MX, Wang JA. Endothelial Progenitor Cells and In stent Restenosls [J]. Curt Stem Cell Res Ther, 2015,10 (4) 364-371.
  • 3Gozal D, Kheirandish Gozal L, Bhattachariee R, et al. Circulat- ing adropin concentrations in pediatric obstructive sleep apnea: potential relevance to endothelial function [J]. J Pediatr, 2013,163(4) : 1122-1126.
  • 4Estrada IA, Donthamsetty R, Debski P, et al. STIM1 restores coronary endothelial function in type 1 diabetic mice [J]. Circ Res, 2012, 111(9):1166 -1175.
  • 5Raina T, Iqbal J, Arnold N, et al. Coronary stents seeded with human trophoblastic endovascular progenitor cells show acceler ated strut coverage without excessive neointimal proliferation in a porcine model[J]. Euro Intervention, 2014, 10(6):709-716.
  • 6McDonald RA, Halliday CA, Miller AM, et al. Reducing In- Stent Restenosis: Therapeutic Manipulation of miRNA in Vas- cular Remodeling and Inflammation[J]. J Am CollCardiol, 2015, 65(21) :2314-2327.
  • 7Peng Z, Qin J, Li B, et al. An effective approach to reduce in flammation and stenosis in carotid artery: polypyrrole nanopar- ticle-based photothermal therapy[J]. Nanoscale, 2015, 7 (17) : 7682-7691.
  • 8Lovren F, Pan Y, Quan A, et al. Adropin is a novel regulator of endothelial function [J]. Circulation, 2010, 122 (11Suppl): 185-192.
  • 9Zhou MH, Zheng H, Si H, et al. Stromal interaction molecule 1 (STIM1) and Orail mediate histamine-evoked calcium entry and nuclear factor of activated T-cells (NFAT) signaling in hu- man umbilical vein endothelial cells [J]. J Biol Chem, 2014, 289 (42) :29446 -29456.
  • 10Deak AT, Groschner LN, Alam MR, et al. The endocannabi- noid N-arachidonoyl glycine (NAGIy) inhibits store-operated Ca^2 + entry by preventing STIM1-Orail interaction [J]. J Cell Sei, 2013, 126(Pt 4):879-888.

引证文献10

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部